08:46 AM EDT, 05/01/2024 (MT Newswires) -- United Therapeutics ( UTHR ) reported Q1 net income Wednesday of $6.17 per diluted share, up from $4.86 a year earlier.

Analysts polled by Capital IQ expected $5.66.

Revenue for the quarter ended March 31 was $677.7 million, up from $506.9 million a year earlier.

Analysts surveyed by Capital IQ expected $624.2 million.

Shares of the biotechnology company were up more than 3% in recent Wednesday premarket activity.

Price: 242.32, Change: +7.99, Percent Change: +3.41